Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198316871> ?p ?o ?g. }
- W3198316871 endingPage "1801" @default.
- W3198316871 startingPage "1786" @default.
- W3198316871 abstract "Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune inflammatory conditions that primarily target the optic nerves, spinal cord, brainstem, and occasionally the cerebrum. NMOSD is characterized by recurrent attacks of visual, motor, and/or sensory dysfunction that often result in severe neurological deficits. In recent years, there has been a significant progress in relapse treatment and prevention but the residual disability per attack remains high. Although symptomatic and restorative research has been limited in NMOSD, some therapeutic approaches can be inferred from published case series and evidence from multiple sclerosis literature. In this review, we will discuss established and emerging therapeutic options for symptomatic treatment and restoration of function in NMOSD. We highlight NMOSD-specific considerations and identify potential areas for future research. The review covers pharmacologic, non-pharmacologic, and neuromodulatory approaches to neuropathic pain, tonic spasms, muscle tone abnormalities, sphincter dysfunction, motor and visual impairment, fatigue, sleep disorders, and neuropsychological symptoms. In addition, we briefly discuss remyelinating agents and mesenchymal stem cell transplantation in NMOSD." @default.
- W3198316871 created "2021-09-13" @default.
- W3198316871 creator A5000750171 @default.
- W3198316871 creator A5002445283 @default.
- W3198316871 creator A5003952631 @default.
- W3198316871 creator A5005622856 @default.
- W3198316871 creator A5006100482 @default.
- W3198316871 creator A5006270755 @default.
- W3198316871 creator A5008002660 @default.
- W3198316871 creator A5008016806 @default.
- W3198316871 creator A5010604563 @default.
- W3198316871 creator A5014850638 @default.
- W3198316871 creator A5016397545 @default.
- W3198316871 creator A5016495852 @default.
- W3198316871 creator A5016844984 @default.
- W3198316871 creator A5017377068 @default.
- W3198316871 creator A5018724144 @default.
- W3198316871 creator A5021031438 @default.
- W3198316871 creator A5024997401 @default.
- W3198316871 creator A5027362230 @default.
- W3198316871 creator A5027873957 @default.
- W3198316871 creator A5029492835 @default.
- W3198316871 creator A5029651525 @default.
- W3198316871 creator A5030868660 @default.
- W3198316871 creator A5032712727 @default.
- W3198316871 creator A5033435187 @default.
- W3198316871 creator A5036433642 @default.
- W3198316871 creator A5037084636 @default.
- W3198316871 creator A5037607617 @default.
- W3198316871 creator A5041415297 @default.
- W3198316871 creator A5043062728 @default.
- W3198316871 creator A5043512810 @default.
- W3198316871 creator A5043687800 @default.
- W3198316871 creator A5043734952 @default.
- W3198316871 creator A5043996334 @default.
- W3198316871 creator A5046479230 @default.
- W3198316871 creator A5048279797 @default.
- W3198316871 creator A5049810809 @default.
- W3198316871 creator A5050636465 @default.
- W3198316871 creator A5051862087 @default.
- W3198316871 creator A5052848358 @default.
- W3198316871 creator A5053403281 @default.
- W3198316871 creator A5057842638 @default.
- W3198316871 creator A5058125590 @default.
- W3198316871 creator A5059662648 @default.
- W3198316871 creator A5064761555 @default.
- W3198316871 creator A5068037677 @default.
- W3198316871 creator A5069433720 @default.
- W3198316871 creator A5070748957 @default.
- W3198316871 creator A5077112559 @default.
- W3198316871 creator A5078840840 @default.
- W3198316871 creator A5079266884 @default.
- W3198316871 creator A5081462122 @default.
- W3198316871 creator A5082565601 @default.
- W3198316871 creator A5083630854 @default.
- W3198316871 creator A5086766200 @default.
- W3198316871 creator A5086775272 @default.
- W3198316871 creator A5086883997 @default.
- W3198316871 creator A5087362850 @default.
- W3198316871 creator A5088301395 @default.
- W3198316871 date "2021-09-05" @default.
- W3198316871 modified "2023-10-17" @default.
- W3198316871 title "Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders" @default.
- W3198316871 cites W1525436179 @default.
- W3198316871 cites W1743037390 @default.
- W3198316871 cites W1776315717 @default.
- W3198316871 cites W1836958062 @default.
- W3198316871 cites W1868773492 @default.
- W3198316871 cites W1885679964 @default.
- W3198316871 cites W1908159338 @default.
- W3198316871 cites W1926204255 @default.
- W3198316871 cites W1962283591 @default.
- W3198316871 cites W1965341586 @default.
- W3198316871 cites W1985118035 @default.
- W3198316871 cites W1987538091 @default.
- W3198316871 cites W1988039811 @default.
- W3198316871 cites W1991019975 @default.
- W3198316871 cites W1998157513 @default.
- W3198316871 cites W2008356917 @default.
- W3198316871 cites W2014806902 @default.
- W3198316871 cites W2016845148 @default.
- W3198316871 cites W2022449896 @default.
- W3198316871 cites W2024996035 @default.
- W3198316871 cites W2025248166 @default.
- W3198316871 cites W2041230047 @default.
- W3198316871 cites W2045586545 @default.
- W3198316871 cites W2047573341 @default.
- W3198316871 cites W2048325305 @default.
- W3198316871 cites W2053472907 @default.
- W3198316871 cites W2056677926 @default.
- W3198316871 cites W2058876334 @default.
- W3198316871 cites W2063974333 @default.
- W3198316871 cites W2067729717 @default.
- W3198316871 cites W2067924801 @default.
- W3198316871 cites W2069232715 @default.
- W3198316871 cites W2069414580 @default.
- W3198316871 cites W2070890080 @default.
- W3198316871 cites W2076868088 @default.